[Characteristics of Lactobacillus strains contained in pharmaceuticals].
The aim of the study was to characterize lactic acid bacteria (LAB) which are components of drugs administered orally in cases of intestinal disturbances, or antibiotic--related diarrhea. Biochemical properties, growth behavior, bile tolerance, and survival at low pH of six LAB strains (four strains L. rhamnosus and two L. acidophilus) were studied. The survival at low pH was determined in MRS broth (Difco) acidified to pH 1; 2; 3; and 4. Bile tolerance was tested on MRS broth with 0.3% oxgall (Difco). Between tested strains differences in ability to grow at low pH and survival in bile were observed. Only 0.01% inoculum of all examined strains survived at pH 1. Differences between strains in survival at low pH (pH 2 and pH 3) and tolerance of bile were observed. However, after 2 h incubation at pH 4, 100% of strains stayed alive. Examined strains demonstrated good 3% bile tolerance. All strains met the criteria for probiotic strains: ability to survive at pH 3 and in the presence of bile.
Banach
W
W
Bucholc
B
B
Wójcik
B
B
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001646:Bile / Q000382:microbiology*; D001647:Bile Acids and Salts / Q000494:pharmacology; D003967:Diarrhea / Q000139:chemically induced / Q000628:therapy*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007778:Lactobacillus / Q000254:growth & development*; D007779:Lactobacillus acidophilus / Q000254:growth & development; D019936:Probiotics
D000900:Anti-Bacterial Agents; D001647:Bile Acids and Salts